Objective: Our aim was to determine the prognostic significance of the systemic-immune-
inflammation index (SIII) in patients with resectable pancreatic cancer, using cancer-specific …

Background The systemic immune-inflammation index based on peripheral neutrophil,
lymphocyte, and platelet counts has shown a prognostic impact in several malignancies …

Background The systemic immune-inflammation index (SII), calculated using absolute
platelet, neutrophil, and lymphocyte counts, has recently emerged as a predictor of survival …

Background Systemic inflammation and immune dysfunction have been proved to be
associated with cancer progression and metastasis in various malignancies. The aim of this …

Background Cancer-associated inflammation is a key molecular feature of pancreatic ductal
adenocarcinoma. In this study, we systematically evaluated the prognostic relevance of …

Different inflammation-based scores such as the neutrophil/lymphocyte ratio (NLR), the
Odonera Prognostic Nutritional Index (PNI), the Glasgow Prognostic Score, the …

Increasing evidence suggests that cancer progression is strongly influenced by host immune
response, which is represented by immune cell infiltrates. T-lymphocyte-based …

Background The systemic immune-inflammation index (SII), integrated by peripheral
lymphocyte, neutrophil, and platelet counts, is used as an objective biomarker that reflects …

Purpose Systemic inflammatory response is a critical factor that promotes the initiation and
metastasis of malignancies including pancreatic cancer (PC). This study was designed to …

Background Many inflammatory markers can be used for the prognostication of pancreatic
cancer, but which combination of inflammatory factors may be the best remains unclear. This …